|
|
|
Insider
Information: |
Hoffman Stephen J |
Relationship: |
Director |
City: |
Carlisle |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
66,559 |
|
Indirect Shares
|
6,603,592 |
|
|
Direct
Value |
$63,911 |
|
|
Indirect Value
|
$70,072,076 |
|
|
Total
Shares |
6,670,151 |
|
|
Total
Value |
$70,135,987 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Allos Therapeutics Inc |
ALTH |
Director |
2012-09-04 |
0 |
2012-09-04 |
0 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2014-02-04 |
1,734,751 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
Director |
2014-02-10 |
0 |
2015-03-17 |
1,992,415 |
Premium* |
|
Acelrx Pharmaceuticals Inc |
ACRX |
|
2024-06-24 |
4,592 |
2014-03-07 |
2,871,933 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
10% Owner |
2014-03-12 |
0 |
2014-03-12 |
4,493 |
Premium* |
|
Aadi Bioscience, Inc |
AADI |
Chief Executive Office... |
2018-11-12 |
31,967 |
2018-11-09 |
0 |
Premium* |
|
Research Alliance Corp. Ii |
RACB |
Director |
2021-03-17 |
30,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GNCA |
Genocea Biosciences, Inc. |
Director |
|
2015-03-17 |
4 |
B |
$8.25 |
$5,775,000 |
I/I |
700,000 |
1,992,415 |
2.1 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
Director |
|
2014-02-10 |
4 |
B |
$12.00 |
$3,011,172 |
I/I |
250,931 |
1,292,415 |
2.1 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2014-02-04 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
1,734,751 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2012-09-04 |
4 |
D |
$1.82 |
$862,081 |
I/I |
(473,671) |
0 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2021-12-28 |
4 |
D |
$38.25 |
$618,005 |
D/D |
(16,157) |
0 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2008-09-02 |
4 |
AS |
$9.68 |
$387,200 |
D/D |
(40,000) |
474,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-11 |
4 |
AS |
$7.30 |
$331,738 |
D/D |
(45,428) |
474,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2009-02-04 |
4 |
AS |
$9.03 |
$328,692 |
D/D |
(36,400) |
474,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-08 |
4 |
AS |
$7.11 |
$322,918 |
D/D |
(45,429) |
474,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-06 |
4 |
AS |
$6.78 |
$308,163 |
D/D |
(45,429) |
474,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-07 |
4 |
AS |
$6.76 |
$307,114 |
D/D |
(45,429) |
474,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-05 |
4 |
AS |
$6.64 |
$301,497 |
D/D |
(45,428) |
474,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2012-09-04 |
4 |
D |
$1.82 |
$167,440 |
D/D |
(92,000) |
0 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-04 |
4 |
AS |
$6.54 |
$166,220 |
D/D |
(25,428) |
474,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Chariman of the Board |
|
2005-05-25 |
4 |
OE |
$0.40 |
$129,995 |
D/D |
248,000 |
474,870 |
|
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-06 |
4 |
OE |
$2.42 |
$109,911 |
D/D |
45,429 |
520,299 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-07 |
4 |
OE |
$2.42 |
$109,911 |
D/D |
45,429 |
520,299 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-08 |
4 |
OE |
$2.42 |
$109,911 |
D/D |
45,429 |
520,299 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-05 |
4 |
OE |
$2.42 |
$109,909 |
D/D |
45,428 |
520,298 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-11 |
4 |
OE |
$2.42 |
$109,909 |
D/D |
45,428 |
520,298 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2008-09-02 |
4 |
OE |
$2.42 |
$96,776 |
D/D |
40,000 |
514,870 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2009-02-04 |
4 |
OE |
$2.42 |
$88,066 |
D/D |
36,400 |
511,270 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
Director |
|
2010-01-04 |
4 |
OE |
$2.42 |
$61,521 |
D/D |
25,428 |
500,298 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
Chief Executive Officer |
|
2018-11-12 |
4 |
B |
$2.01 |
$60,300 |
D/D |
30,000 |
31,967 |
2.81 |
- |
|
ALTH |
Allos Therapeutics Inc |
Chariman of the Board |
|
2004-03-23 |
4 |
A |
$18.00 |
$7,200 |
I/I |
400 |
100 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|